Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (317)	4/19/2004 11:09:05 PM
From: ~digs	Read Replies (1) \| Respond to of 7944

update: EPMD @ 3.250 +0.050 1.56% 809K 3:59 PM solid volume again today but not much movement news today: April 19, 2004--EP MedSystems, Inc. (NASDAQ: EPMD - News), a market leader in electrophysiology products used to diagnose and treat certain types of cardiac rhythm disorders, announced today that it had received market clearance from the FDA for its line of deflectable diagnostic catheters. A deflectable catheter allows the physician to deflect its tip to steer the catheter into certain vessels and areas of the heart, which would be difficult with a fixed curve catheter. These catheters connect to the Company's EP-WorkMate® Electrophysiology Workstation, as well as other technologies that and are used in the monitoring and diagnosis of arrhythmias in the heart. finance.yahoo.com